cBioPortal analysis indicated that mutations in the genes encoding p62, Keap1, and Nrf2 were present in these patients, and 15% of patients with thyroid cancer exhibited mutations in SOSTM1, KEAP1, or NFE2L2. This evidence concerns the gene NFE2L2 and thyroid cancer.